Non-conserved residues in the central cytoplasmic domain of Ca2+-ATPase are involved in E1P to E2P conformational changes, while transmembrane segments form Ca2+-binding sites.
Domain mapping in Ca2+-ATPase chimeras advances pump mechanism models; leaves open relevance to cardiac Ca2+ handling in vivo.
Chimeric molecules consisting of parts from the sarcoplasmic reticulum Ca(2+)-ATPase and the Na+,K(+)-ATPase were expressed in COS-1 cells and analysed functionally. One chimera, in which most of the central cytoplasmic loop was derived from the Na+,K(+)-ATPase, while the transmembrane segments and the minor cytoplasmic loop came from the Ca(2+)-ATPase, was able to occlude Ca2+ and to be phosphorylated from ATP with normal apparent affinity for Ca2+ and ATP. This chimera also displayed normal sensitivity to thapsigargin, but was unable to undergo the transition from ADP-sensitive to ADP-insensitive phosphoenzyme and to transport Ca2+. The other chimera, which consisted of the NH2-terminal two-thirds of Na+,K(+)-ATPase and the COOH-terminal one-third of Ca(2+)-ATPase, was unable to phosphorylate from ATP, but phosphorylated from inorganic phosphate in a Ca(2+)-inhibitable and thapsigargin-insensitive reaction. These results can be explained in terms of a structural model in which the non-conserved residues in the central cytoplasmic domain of the Ca(2+)-ATPase are without major importance for the binding and occlusion of Ca2+, but are involved in the E1P-->E2P conformational changes of the phosphoenzyme, whereas residues in transmembrane segments on both sides of the central cytoplasmic domain are involved in formation of the Ca(2+)-binding sites. The data moreover show that thapsigargin sensitivity is dependent on residues in the NH2-terminal one-third of the Ca(2+)-ATPase molecule.
No takes yet. Share an insight, caveat, or question.
Nørregaard et al. (1993) studied this question.